chromocell.com (CHRO) - Volume dana dhuwit perusahaan

Simbol resmi perusahaan Chromocell Therapeutics (CHRO)

Chromocell Therapeutics (CHRO) is expanding its pipeline of ion channel-based analgesics while minimizing R&D risks. The cash balance illustrates financial stability, and the 0.00 indicator shows the latest value of this metric. The race for innovation in the analgesic segment requires massive expenditures, while strict FDA oversight and reliance on investment determine the success of the entire ecosystem.

CHRO - Cadangan dhuwit perusahaan Chromocell Therapeutics Corporation ing rentang 21.02.2024 - 02.07.2025

Rincian analitis perusahaan Chromocell Therapeutics

Pambiji fundamental perusahaan:Chromocell Therapeutics Corp
Produk merek Chromocell Therapeutics Corp.

This metric determines the issuer's ability to fund expansion without resorting to costly debt. By analyzing cash flow dynamics, an investor assesses the liquid reserve available for strategic investments. The metric aggregates current account balances and highly liquid equivalents, measuring the business's actual financial potential. For Chromocell Therapeutics (CHRO), such resources are critical for maintaining expensive laboratories, which allows the company to retain leading neurobiologists by providing them with complete creative freedom.

Pesaing Chromocell Therapeutics (CHRO)

Volume dana dhuwit perusahaan BIIB|Dana dhuwit perusahaan NBIX (Neurocrine Biosciences)|Dana dhuwit perusahaan Regencell Bioscience Ltd RGC|AXSM (Axsome Therapeutics, Inc.) - Total volume dana dhuwit perusahaan|ACADIA Corp - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Xenon Pharmaceuticals|VKTX (Viking Therapeutics Corp) - Dhuwit awis perusahaan|Supernus Pharmaceuticals (SUPN) - Volume dana dhuwit perusahaan|CPRX (Catalyst Pharma) - Volume dana dhuwit perusahaan|DNLI (Denali Therapeutics Inc.) - Gunggung dana dhuwit perusahaan|Volume dana dhuwit perusahaan HRMY|Biohaven Corp - Dhuwit awis lan setara dhuwit awis perusahaan|Volume dana dhuwit perusahaan AMLX (amylyx.com)|Aset likuid perusahaan Trevi Therapeutics, Inc. (TRVI)|Praxis Corp - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Anavex|CBLL (CeriBell Inc) - Dhuwit awis perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan PRTA|Dana dhuwit perusahaan Alector Inc.|Cadangan dhuwit perusahaan Annexon, Inc. ANNX|Dana dhuwit perusahaan Omeros Corp (OMER)|NGNE (Neurogene Inc) - Sisa dhuwit perusahaan|Dana dhuwit perusahaan AC Immune Inc ACIU|Posisi dhuwit perusahaan Voyager Corp|Neumora Corp - Volume dana dhuwit perusahaan|scilexholding.com (SCLX) - Dhuwit awis perusahaan|Tevogen Bio Holdings, Inc. (TVGN) - Dana dhuwit perusahaan|Alpha Cognition Corp (ACOG) - Volume dana dhuwit perusahaan|Dhuwit awis perusahaan CGTX|Dhuwit awis lan setara dhuwit awis perusahaan IKT (Inhibikase)|Volume dana dhuwit perusahaan SAVA|Assertio - Dhuwit awis lan setara dhuwit awis perusahaan|Volume dana dhuwit perusahaan COYA (Coya Therapeutics)|Volume dana dhuwit perusahaan Vistagen Therapeutics VTGN|OVID: Dhuwit awis perusahaan|ABOS - Volume dana dhuwit perusahaan|CRVO: Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Alterity Therapeutics Ltd. (ATHE)|Dana dhuwit perusahaan Clene Inc.|pepgen.com (PEPG) - Aset likuid perusahaan|Dhuwit awis perusahaan JUNS (jupiterneurosciences.com)|Dana dhuwit perusahaan RLMD (Relmada Corp)|Annovis Bio, Inc. - Dhuwit awis perusahaan|Posisi dhuwit perusahaan Grace Therapeutics, Inc.|Firefly Neuroscience, Inc - Volume dana dhuwit perusahaan|KLTO - Volume dana dhuwit perusahaan|NRSN (NeuroSense Therapeutics Ltd.) - Dhuwit awis perusahaan|RVPH - Aset likuid perusahaan|Dana dhuwit perusahaan MetaVia|Dhuwit awis lan setara dhuwit awis perusahaan NRXS (neuraxis.com)|Dana dhuwit perusahaan Helius Medical Technologies (HSDT)|PASG (Passage Bio) - Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan NEUP (Neuphoria Therapeutics)|Sisa dhuwit perusahaan NERV|ATHA - Dana dhuwit perusahaan|Total volume dana dhuwit perusahaan ADXN|ALZN (Alzamend Neuro) - Dhuwit awis perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan CYCN|PTIX (Protagenic Therapeutics, Inc.) - Volume dana dhuwit perusahaan|KTTA: Sisa dhuwit perusahaan|Dana dhuwit perusahaan Cortigent Medical (CRGT)|ATXI - Cadangan dhuwit perusahaan|Volume dana dhuwit perusahaan BCLI (Brainstorm Cell Therapeutics Inc.)|Cara Therapeutics, Inc (CARA) - Cadangan dhuwit perusahaan|Eliem Therapeutics Inc. - Volume dana dhuwit perusahaan|ITCI - Volume dana dhuwit perusahaan|Longboard Pharma (LBPH) - Dana dhuwit perusahaan|Dhuwit awis perusahaan Marinus Pharmaceuticals|Dana dhuwit perusahaan NKGen|Volume dana dhuwit perusahaan NeuroBo Pharmaceuticals, Inc.|Volume dana dhuwit perusahaan SAGE|Synaptogenix, Inc - Dhuwit awis lan setara dhuwit awis perusahaan|Dana dhuwit perusahaan Trevena TRVN|Posisi dhuwit perusahaan Vigil Neuroscience|Anew Medical Inc. - Volume dana dhuwit perusahaan|Aset likuid perusahaan Cerevel Therapeutics, Inc. CERE